Robin Winter-Sperry
Dr. Robin Winter-Sperry started working in the industry in the area of Dermatology. She has had a long and distinguished career including Sanofi/Genzyme Global Medical Affairs, Strategy & Tactics in the area of Multiple Sclerosis and President and CEO of Scientific Advantage, LLC. She created Novartis’ Medical Science Liaison (MSL) department of Scientific Operations and Sanofi-Synthelabo’s Medical Therapeutic Liaison division.
She has been involved in over 28 product launches. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams.
HUBERT BLAND
Hubert joined BMS in November 2020, bringing more than 20 years of experience in product launches, drug development and approval, and Medical Team leadership to his new role in Major Markets Medical.
He is a recognised industry leader, and champion of the Medical team in Biopharma. In addition to having worked on over 200 industry and academic studies across a range of indications in oncology, immunology, CV, metabolic and exercise medicine – he is also a passionate and accomplished medical communicator, previously hosting a weekly radio show and as well as several appearances on TV.
He joined BMS from Sanofi where he held roles as Country Medical Lead UKIE and Global Lead for FBME since 2016. He has held several senior medical leadership positions previously within Pfizer, Boehringer-Ingelheim, BOC, academia and consultancy.
